| Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women (NCT06776055) | Shanghai Zerun Biotechnology Co.,Ltd | 2023-03-27 |
| Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 (NCT05580341) | Shanghai Zerun Biotechnology Co.,Ltd | 2022-09-01 |
| Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults. (NCT05490108) | Shanghai Zerun Biotechnology Co.,Ltd | 2022-06-02 |
| Safety and Immunogenicity of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 (NCT05313022) | Shanghai Zerun Biotechnology Co.,Ltd | 2022-01-18 |
| Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 (NCT04990544) | Shanghai Zerun Biotechnology Co.,Ltd | 2021-07-31 |
| Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 (NCT04982068) | Shanghai Zerun Biotechnology Co.,Ltd | 2021-07-12 |
| Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females (NCT04965350) | Shanghai Zerun Biotechnology Co.,Ltd | 2021-04-20 |
| A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine (NCT03900572) | Shanghai Zerun Biotechnology Co.,Ltd | 2019-03-09 |
| Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females (NCT02740777) | Shanghai Zerun Biotechnology Co.,Ltd | 2016-02-01 |
| A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine. (NCT02733068) | Shanghai Zerun Biotechnology Co.,Ltd | 2014-11-02 |
| Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females (NCT02740790) | Shanghai Zerun Biotechnology Co.,Ltd | 2013-09-01 |
| Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females (NCT01548118) | Shanghai Zerun Biotechnology Co.,Ltd | 2012-02-01 |